HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between integrin expression and prognosis in localized prostate cancer.

AbstractBACKGROUND:
Integrins and other adhesion molecules are essential for maintaining the epithelial phenotype. Some studies have reported correlations between abnormalities in their expression and carcinogenesis, but their role in prostate cancer is unclear. Our aim was to study the expression profile of integrins in surgical specimens of prostate cancer and associate their expression patterns with patient outcomes.
METHODS:
We selected 111 patients with localized prostate cancer who had undergone radical prostatectomy. Of these patients, 60 had no tumor recurrence after a median follow-up of 123 months. Integrin expression was evaluated by immunohistochemistry in a tissue microarray containing two tumor samples per patient. A semiquantitative analysis was employed. We measured the association between the expression of eight integrins and tumor recurrence.
RESULTS:
Multivariate analysis showed that expression of alpha3 and alpha3beta1 was related to worse outcome. When alpha3 expression was strong and alpha3beta1 expression was positive, the odds of recurrence were 3.0- and 2.5-fold higher, respectively. Only 19% and 28% of patients were recurrence-free in a mean period of 123 months of follow up when their tumors showed strong alpha3 or positive alpha3beta1 immuno-expression, respectively.
CONCLUSIONS:
We have shown that the expression of integrin alpha3beta1 was independently associated with tumor recurrence after radical prostatectomy, suggesting that this integrin is a potential prognostic marker.
AuthorsJosé Pontes-Júnior, Sabrina Thalita Reis, Luis Carlos Neves de Oliveira, Alexandre C Sant'anna, Marcos Francisco Dall'oglio, Alberto Azoubel Antunes, Leopoldo Alves Ribeiro-Filho, Paulo Afonso Carvalho, Jose Cury, Miguel Srougi, Kátia Ramos Moreira Leite
JournalThe Prostate (Prostate) Vol. 70 Issue 11 Pg. 1189-95 (Aug 2010) ISSN: 1097-0045 [Electronic] United States
PMID20564421 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright2010. (c) 2010 Wiley-Liss, Inc.
Chemical References
  • Biomarkers, Tumor
  • Integrins
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (biosynthesis, genetics)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Integrins (biosynthesis, genetics)
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (genetics, metabolism, pathology)
  • Prognosis
  • Prostatic Neoplasms (genetics, metabolism, pathology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: